CHINELLO, CLIZIA
 Distribuzione geografica
Continente #
NA - Nord America 9.217
EU - Europa 5.181
AS - Asia 2.034
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 10
AF - Africa 7
Totale 16.483
Nazione #
US - Stati Uniti d'America 9.048
IT - Italia 1.431
DE - Germania 885
CN - Cina 792
IE - Irlanda 727
SG - Singapore 716
SE - Svezia 603
RU - Federazione Russa 352
GB - Regno Unito 259
AT - Austria 232
UA - Ucraina 227
HK - Hong Kong 205
CA - Canada 166
FI - Finlandia 97
FR - Francia 96
VN - Vietnam 86
DK - Danimarca 83
ID - Indonesia 66
IN - India 59
BE - Belgio 42
NL - Olanda 41
TR - Turchia 22
ES - Italia 21
PL - Polonia 21
CZ - Repubblica Ceca 17
JP - Giappone 16
KR - Corea 14
RO - Romania 14
BR - Brasile 13
IR - Iran 12
TW - Taiwan 12
CH - Svizzera 11
AU - Australia 10
EU - Europa 10
PH - Filippine 7
IL - Israele 6
TH - Thailandia 6
BG - Bulgaria 5
CL - Cile 4
GR - Grecia 4
AR - Argentina 3
LU - Lussemburgo 3
MY - Malesia 3
NO - Norvegia 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
EC - Ecuador 2
HR - Croazia 2
LT - Lituania 2
MA - Marocco 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BT - Bhutan 1
EG - Egitto 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
MX - Messico 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 16.483
Città #
Ann Arbor 2.127
Fairfield 773
Chandler 722
Dublin 718
Singapore 631
Woodbridge 626
Frankfurt am Main 599
Milan 561
Wilmington 530
Houston 506
Ashburn 483
Dearborn 358
Seattle 310
Santa Clara 278
New York 249
Cambridge 244
Jacksonville 233
Vienna 225
Hong Kong 200
Princeton 175
Shanghai 170
Nanjing 135
Jakarta 66
Lawrence 63
Altamura 62
Beijing 62
Fremont 59
Nanchang 56
Helsinki 50
Dong Ket 48
Guangzhou 46
Lachine 40
Brussels 39
San Diego 39
Montréal 38
Ottawa 38
Los Angeles 34
Toronto 30
Shenyang 29
Lissone 27
London 26
Andover 25
Chicago 23
Hebei 23
Munich 22
Changsha 20
Florence 20
Tianjin 20
Zhengzhou 20
Caronno Pertusella 19
Falls Church 19
Kunming 19
Pune 19
Boardman 18
Jiaxing 18
Jinan 18
Cinisello Balsamo 17
Brescia 16
Madison 16
Ningbo 16
Norwalk 16
Rome 16
Pavia 15
Como 14
Edmonton 14
Brno 13
Kiev 13
Ripalta Cremasca 13
Romola 12
Washington 12
Dallas 11
Hangzhou 11
Melzo 11
Bonndorf 10
Genoa 10
Mountain View 10
Padova 9
Taizhou 9
Verona 9
Bergamo 8
Cagliari 8
Carate Brianza 8
Huizen 8
Monza 8
Napoli 8
Terni 8
Kilburn 7
Lille 7
Messina 7
Minamikasugaoka 7
Nürnberg 7
Sacramento 7
Vercelli 7
Amsterdam 6
Atlanta 6
Kelty 6
Kraków 6
Legnano 6
Lodi 6
Paris 6
Totale 12.448
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 426
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 361
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 357
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 340
Differential protein profiling of renal cell carcinoma urinary exosomes 324
Urinary exosomes and diabetic nephropathy: a proteomic approach 298
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 274
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 274
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 272
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 270
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 262
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 261
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 259
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 256
The proteomic landscape of renal tumors 249
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 239
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 239
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 238
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 236
The putative role of MALDI-MSI in the study of Membranous Nephropathy 234
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 234
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 231
Robust conclusions in mass spectrometry analysis 228
Mutual Information Optimization for Mass Spectra Data Alignment 227
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 223
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 216
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 216
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 215
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 209
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 208
Tumor size, stage and grade alterations of urinary peptidome in RCC 205
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 204
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 201
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 200
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 198
Proteome analysis in thyroid pathology 196
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 191
Analysis of correlation structures in renal cell carcinoma patient data 187
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 184
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 183
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 182
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 182
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 180
Imaging mass spectrometry: a new tool for kidney disease investigations 174
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 166
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 166
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 164
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 160
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 159
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 158
Intraluminal proteome and peptidome of human urinary extracellular vesicles 158
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 156
A molecular imaging approach to individuate tumour infiltrating lymphocytes 155
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 154
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 151
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 150
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 150
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 148
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 141
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 140
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 138
AQP1 expression analysis in human diseases: Implications for proteomic characterization 135
Proteomics imaging and the kidney 134
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 131
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 129
Immunoreattività e carcinoma renale 128
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 128
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 125
Characterization of distinguishing regions for Renal Cell Carcinoma discrimination 123
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 120
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 120
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 116
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 113
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 106
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 96
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 96
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 94
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 92
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 90
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 86
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 86
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 86
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 84
Method for the in vitro diagnosis of thyroid diseases 84
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 82
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 79
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 79
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 79
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 75
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 73
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 73
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 72
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 72
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 68
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 67
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 66
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 66
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 65
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 60
A Blood Bank Standardized Production of Human Platelet Lysate for Mesenchymal Stromal Cell Expansion: Proteomic Characterization and Biological Effects 58
Totale 16.793
Categoria #
all - tutte 57.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.665


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.732 0 0 0 0 0 349 434 209 267 202 195 76
2020/20212.733 122 148 294 286 220 225 329 292 205 224 154 234
2021/20221.539 145 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.325 68 67 106 173 249 652 481 56 144 44 53 232
2024/20251.948 222 473 345 220 481 207 0 0 0 0 0 0
Totale 17.304